Guidance
Specialist and reference microbiology: laboratory tests and services
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
- From:
- UK Health Security Agency
- Published
- 18 July 2014
- Last updated
-
23MayFebruary20242026 — See all updates
Important service update
To enable UK Health Security Agency (UKHSA) reference and specialist laboratories to continue to provide critical support to the enhanced COVID-19 incident, some service delivery changes have been made with immediate effect.
The following updates have since been issued:
- Legionella services (urine antigen testing, PCR, culture and typing) are unaffected (see user manual for details)
- Streptococcal identification and typing services are offered as routine, with priority to outbreak typing (GBS and GAS)
- Mycoplasma pneumoniae macrolide resistance testing is not suspended, but samples may be batched and turnaround times may be extended
The situation will be regularly reviewed. For the most current information, contact the relevant department using the contact details provided in the BRD user manual or VRD user manual.
More information about the tests, services and reference units are available from the unit pages.
Tests and services
| Services | Test type | Request form | Unit |
|---|---|---|---|
| Acanthamoeba | For keratitis/ophthalmic samples only | Contact the Diagnostic Parasitology Laboratory at the London School of Hygiene and Tropical Medicine | LSHTM |
| Achromobacter | Species identification, molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Acinetobacter | Species identification, molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Actinomycetes (Aerobic) | Antimicrobial susceptibility | H1, H2 | AMRHAI |
| Actinomycetes (Aerobic) | Identification and confirmation | M1, H2 | AMRHAI |
| Adenoviruses (enteric) | PCR | E1 | EVU |
| Adenoviruses (respiratory) | PCR | E27 | RVU |
| Amoebae (excluding Acanthamoeba keratitis) | Detection, identification and confirmation, serodiagnosis | Contact National parasitology reference laboratory (NPRL) | NPRL |
| Anaerobes (bacteroides, clostridia, fusobacteria, actinomyces spp., other closely related genera) | Identification | Contact ARU | ARU |
| Anthrax | See Bacillus anthracis | ||
| Antibiotic resistance surveys | European antibiotic resistance surveillance scheme (EARSS) and surveillance of resistance | H1 | AMRHAI |
| Antibiotic susceptibility testing | New antimicrobials, susceptibility testing service, beta-lactamases, endocarditis | H1, H2 | AMRHAI |
| Arboviruses (bunyaviridae, flaviviridae, togaviridae) | Isolation, serology, PCR | P1 | RIPL |
| Aspergillus | Identification and confirmation | Y1 or Y2 | Mycology RL |
| Astrovirus | RT-PCR | E1 | EVU |
| Astrovirus | Genotyping | Contact EVU | EVU |
| Bacillus anthracis | Identification and confirmation, PCR, serology, characterisation (phage, penicillin sensitivity) | Contact RIPL lab | RIPL |
| Bacillus (other than B.anthracis) | Identification | L4 | GBRU |
| Bacillus (other than B.anthracis) | Molecular typing | L4 | GBRU |
| Bacillus (other than B.anthracis) | Detection of emetic toxin gene by PCR | L4 | GBRU |
| Bacillus (other than B.anthracis) | Antimicrobial susceptibility | H1, H2 | AMRHAI |
| Bacterial Identification Service (BIDS) - isolates | Isolate identification (unknown, atypical, fastidious, emerging bacteria) | M1 | AMRHAI |
| Bacterial Identification Service (BIDS) - clinical samples | Bacterial detection and species identification for culture-negative, unknown clinical samples from normally sterile sites | M1 | AMRHAI |
| Blastomyces dermatidis | Serology, identification and confirmation | Y1 or Y2 | MRL |
| Bordetella spp. | Identification | R3 | RVPBRU |
| Bordetella spp. | Antimicrobial susceptibility | H1, H2 | AMRHAI |
| Bordetella pertussis | Serology: anti-PT IgG antibodiesNot suitable for immune status | R3 | RVPBRU |
| Bordetella pertussis | Oral fluid: anti-PT IgG antibodies. NOT suitable for immune status | Form distributed with kit | RVPBRU |
| Bordetella pertussis | qPCR | R3 | RVPBRU |
| Brucella spp. | Serodiagnosis | Y3 | BRU |
| Brucella spp. | Speciation and characterisation | Contact AHVLA laboratory, Weybridge | BRU |
| Burkholderia spp. | Species identification, molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Burkholderia pseudomallei | Identification and antimicrobial resistance | H1, H2 | AMRHAI |
| Candida spp. | Identification and confirmation | Y1 or Y2 | Mycology RL |
| Campylobacter | Antibiotic susceptibility testing for gram negative GI pathogens | L4 | GBRU |
| Campylobacter | Identification | L4 | GBRU |
| Chikungunya virus | Serology, PCR | P1 | RIPL |
| Chlamydia (respiratory) | Only available after discussion and prior agreement with RVPBRU C. pneumoniae, C. psittacci, C. abortus: PCR assay | For urgent enquiries, contact RVPBRU | RVPBRU |
| Chlamydia trachomatis | C. trachomatis: LGV multiplex PCR | B7 | CSU |
| Clostridium difficile | 16S/23S PCR ribotyping, antibiotic susceptibility testing and toxin A and B assay on isolates | Contact ARU | ARU |
| Clostridium botulinum | Detection and identification of C. botulinum from clinical, food or environmental samples by PCR and culture | L4 | GBRU |
| Clostridium botulinum | Detection of botulinum neurotoxins in clinical specimens or food | L4, L7 | GBRU |
| Clostridium perfringens | Identification of enterotoxigenic C. perfringens by PCR | L4 | GBRU |
| Clostridium perfringens | Molecular typing | L4 | GBRU |
| Clostridium perfringens | Detection of C. perfringens enterotoxin in faeces by ELISA | L4 | GBRU |
| Clostridium perfringens | C. perfringens Toxin (lethal toxins) typing by PCR | L4 | GBRU |
| Clostridium tetani | Detection and identification of C. tetani by PCR and culture | L4 | GBRU |
| Clostridium tetani | Detection of C. tetani neurotoxin in serum (note: serum will be first tested for tetanus antibody levels by RVPBRU) | L4 | GBRU |
| Clostridium tetani | Tetanus immunity: serum antibodies | R3 | RVPBRU |
| Coccidioides immitis | Serology, identification and confirmation | Y1 or Y2 | Mycology RL |
| Coronavirus | Virus detection by PCR (sequencing) | E16 | RVU |
| Coronavirus (SARS) | Contact laboratory prior to collection of samples | E16 | RVU |
| Coronavirus (SARS-CoV-2) | Confirmatory testing | V30 | regional UKHSA |
| Coronavirus (MERS-CoV) | Contact laboratory prior to collection of samples | E16 | RVU |
| Corynebacterium | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Corynebacterium diphtheriae | C. diphtheriae and other potentially toxigenic corynebacteria: identification and toxin testing by PCR and Elek | R3 | RVPBRU |
| Corynebacterium diphtheriae | Diphtheria immunity: serum antibodies | R3 | RVPBRU |
| Corynebacterium jeikeium | C. jeikeium antimicrobial sensitivity | H2 | AMRHAI |
| Crimean-Congo haemorrhagic fever | Serology, PCR. Please contact lab before sending samples. | P1 | RIPL |
| Cronobacter | C. sakazakii: confirmation of identification, molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Cystic Fibrosis (CF) pathogens | Identification and molecular typing | H2 | AMRHAI |
| Cystic Fibrosis (CF) pathogens | Antimicrobial susceptibility | H1, H2 | AMRHAI |
| Cryptococcus spp. | Identification and confirmation | Y1 or Y2 | Mycology RL |
| Cryptosporidium spp. | Detection, identification and confirmation, typing | Contact CRU | CRU |
| Dengue virus | Serology, PCR | P1 | RIPL |
| Dermatophytes | Identification, confirmation | Y1 or Y2 | Mycology RL |
| Diphtheria (see Corynebacterium diphtheriae) | |||
| Ebola virus | Serology, PCR. Please contact lab before sending samples. | P1 | RIPL |
| Elizabethkingia.spp | Identification, molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Enterobacter spp. | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Enterococcus spp. | Species identification, molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Enterovirus | RT-PCR | E1 | EVU |
| Enterovirus | Virus culture | Contact EVU | EVU |
| Enterovirus | Typing | E1 | EVU |
| Escherichia | E. coli (ACDP HG 2 only): molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Escherichia | Identification and typing | L4 | GBRU |
| Escherichia | Detection and isolation from faeces | L5 | GBRU |
| Francisella spp., including tularensis | PCR, serology, isolation | P1 | RIPL |
| Gram-negative bacteria non fermenter and fastidious organisms | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Gram-positive bacteria (except C.diphtheriae) | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Haemophilus | Haemophilus ducreyi: PCR | B3 | |
| Haemophilus | Haemophilus spp. (excluding H. ducreyi): identification | R3 | RVPBRU |
| Haemophilus | H. influenzae: sero typing and capsular genotyping of H.influenzae | R3 | RVPBRU |
| Haemophilus spp. and Aggregatibacter spp. | Antimicrobial susceptibility | H1, H2 | AMRHAI |
| Haemorrhagic fever viruses (filoviridae, arenaviridae, Bunyaviridae) | Serology, PCR. Please contact lab before sending samples. | P1 | RIPL |
| Hantavirus | Serology, PCR. | P1 | RIPL |
| Hendra virus | Serology, PCR. Please contact lab before sending samples. | P1 | RIPL |
| Helicobacter | H. pylori identification and antibiotic susceptibility | L4,L5 | GBRU |
| Hepatitis A virus (HAV) | RNA | S1 | BBVU |
| Hepatitis A virus (HAV) | Genotyping and phylogenetics | S1 | BBVU |
| Hepatitis A virus (HAV) | Anti-HAV IgG and IgM | S1 | CSU |
| Hepatitis B virus (HBV) | HBsAg detection | S1 | CSU |
| Hepatitis B virus (HBV) | HBsAg quantification | S1 | CSU |
| Hepatitis B virus (HBV) | HBsAg neutralisation | S1 | CSU |
| Hepatitis B virus (HBV) | HBeAg | S1 | CSU |
| Hepatitis B virus (HBV) | Anti-HBc | S1 | CSU |
| Hepatitis B virus (HBV) | Anti-HBc IgM | S1 | CSU |
| Hepatitis B virus (HBV) | Anti-HBs | S1 | CSU |
| Hepatitis B virus (HBV) | Anti-HBe | S1 | CSU |
| Hepatitis B virus (HBV) | DNA viral load | S1 | CSU |
| Hepatitis B virus (HBV) | Pre-core and BCP mutation screen | S10 | BBVU |
| Hepatitis B virus (HBV) | Surface mutation screen | S10 | BBVU |
| Hepatitis B virus (HBV) | Antiviral resistance | S10 | BBVU |
| Hepatitis B virus (HBV) | Genotyping and phylogenetics | S10 | BBVU |
| Hepatitis C virus (HCV) | Antibody confirmation and viral load | S1 | CSU |
| Hepatitis C virus (HCV) | Antibody confirmation (dried blood spots and oral fluid samples) | S1 | BBVU |
| Hepatitis C virus (HCV) | Viral load | S1 | CSU |
| Hepatitis C virus (HCV) | Viral load (sensitivity >15 IU/ml) Please contact lab prior to sample referral | S1 | CSU |
| Hepatitis C virus (HCV) | Qualitative RNA detection | S1 | BBVU |
| Hepatitis C virus (HCV) | Genotyping (NS5B sequencing): EDTA plasma | S1 | CSU |
| Hepatitis C virus (HCV) | Genotyping (NS5B sequencing): dried blood spots | S1 | BBVU |
| Hepatitis C virus (HCV) | Phylogenetics | S1 | BBVU |
| Hepatitis C virus (HCV) | HCV DAA genotypic resistance | Contact AVU | AVU |
| Hepatitis Delta virus (HDV) | Anti-HDV IgG | S1 | CSU |
| Hepatitis Delta virus (HDV) | Anti-HDV IgM | S1 | CSU |
| Hepatitis Delta virus (HDV) | RNA | S1 | BBVU |
| Hepatitis E virus (HEV) | Anti-HEV IgG | S1 | CSU |
| Hepatitis E virus (HEV) | Anti-HEV IgM | S1 | CSU |
| Hepatitis E virus (HEV) | RNA | S1 | BBVU |
| Hepatitis E virus (HEV) | Genotyping, phylogenetics | S1 | BBVU |
| Herpes simplex virus (HSV 1 and 2) | Phenotypic drug resistance | Contact AVU | AVU |
| Herpes simplex virus (HSV 1 and 2) | Intrathecal antibody testing | E22 | IDU |
| Histoplasma capsulatum | Serology, identification and confirmation | Y1 or Y2 | Mycology RL |
| Histology slides | Examination for the presence of fungi | Y1 or Y2 | Mycology RL |
| HIV-1 and HIV-2 | HIV 1, HIV-2 antibody screen, confirmation, typing | S3 | CSU |
| HIV-1 and HIV-2 | HIV 1, HIV-2 antibody screen, confirmation, typing (dried blood spots) | S3 | CSU |
| HIV-1 and HIV-2 | HIV 1, HIV-2 antibody screen, confirmation, typing, oral fluid (OraSure) | S3 | CSU |
| HIV-1 and HIV-2 | HIV-1 proviral DNA | S3 | CSU |
| HIV-1 and HIV-2 | HIV-1 RNA quantification (viral load) | S3 | CSU |
| HIV-1 and HIV-2 | HIV-1 p24 antigen with neutralisation | S3 | CSU |
| HIV-1 and HIV-2 | HIV-1 incidence testing (avidity) | S3 | CSU |
| HIV-1 and HIV-2 | HIV-1 genotypic resistance | S9 | AVU |
| HIV-1 and HIV-2 | HIV-1 proviral tropism testing | S9 | AVU |
| HIV-1 and HIV-2 | Detection of minority drug resistance mutants | S9 | AVU |
| HIV-1 and HIV-2 | HIV-1 sequencing and sequence comparison | Contact AVU | AVU |
| Human T-lymphotropic virus type I and Human T-lymphotropic virus type II (HTLV-I and II) | HTLV antibody screen, confirmation, typing | S5 | CSU |
| Human T-lymphotropic virus type I and Human T-lymphotropic virus type II (HTLV-I and II) | HTLV type-specific PCR | S5 | CSU |
| Human herpesvirus 6 (HHV-6) | PCR and genotyping | E18 | IDU |
| Human herpesvirus 7 (HHV-7) | PCR | E18 | IDU |
| Human herpesvirus 8 (HHV-8) | Quantitative DNA PCR | S19 | CSU |
| Human metapneumovirus | Virus detection by PCR andsequencing | Contact RVU | RVU |
| Hydatid disease or Echinococcosis | Serology | Contact NPRL | NPRL |
| Identification of bacterial isolates with no national reference facility (unknowns, atypical, fastidious, emerging | MALDI-TOF-MS, 16s ribosomal sequence analysis | M1 | AMRHAI |
| Infection prevention and control | testing | Contact AMRHAI | AMRHAI |
| Influenza | Virus detection by multiplex PCR | E3 | RVU |
| Influenza | Strain typing HAI | E3 | RVU |
| Influenza | Antibody response HAI | E2 | RVU |
| Influenza | Phenotypic drug resistance | Contact RVU | RVU |
| Influenza | Genotypic drug resistance by pyrosequencing and SNP PCR | Contact RVU | RVU |
| Influenza | Genotypic drug resistance by gene sequencing | Contact RVU | RVU |
| Influenza (avian) | Confirmation of regional laboratory H9 virus detection | Contact RVU | RVU |
| Influenza (avian) | Antibody response | Contact RVU | RVU |
| JC virus (see Polyomavirus) | PCR | E13 | IDU |
| Klebsiella spp. | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Lassa virus | Serology, PCR. Please contact lab before sending samples. | P1 | RIPL |
| Legionella | L.pneumophila: in-house urinary antigen EIA assay (confirmation of sending lab testing results only) | R1 | RVPBRU |
| Legionella | L pneumophila PCR (from urinary antigen positive patients only) | R1 | RVPBRU |
| Legionella | Identification and epidemiological typing of clinical or outbreak associated isolates | R1 | RVPBRU |
| Leuconostoc spp. | Antimicrobial susceptibility | H1, H2 | AMRHAI |
| Leptospira spp | Isolation and confirmation, identification, serology | Leptospirosis: request form | NLS |
| Listeria spp. | Identification, serotyping and molecular typing of L.monocytogenes | L4 | GBRU |
| Listeria spp. | Species identification of Listeria | L4 | GBRU |
| Listeria spp. | Antimicrobial susceptibility | H1, H2 | AMRHAI |
| Lyme disease | Serology, PCR | P2 | RIPL |
| Malaria | Blood film diagnosis, antigen detection, PCR, drug resistance markers | Malaria report form | Malaria RL |
| Marburg virus | Serology, PCR. Please contact lab before sending samples. | P1 | RIPL |
| Measles | IgG and IgM serology for recent infection | E8 | IDU |
| Measles | IgG antibody status | E8 | IDU |
| Measles | Intrathecal antibody testing | E22 | IDU |
| Measles | PCR | E8 | IDU |
| Measles | Plaque reduction neutralisation assay | E8 | IDU |
| Middle East respiratory syndrome coronavirus (MERS-CoV) | Contact laboratory prior to collection of specimens | E16 | RVU |
| Molluscum contagiosum | Electron microscopy | E17 | HPU |
| Moulds | Identification and confirmation, susceptibility testing | Y1 or Y2 | Mycology RL |
| Methicillin-resistant staphylococcus aureus (MRSA) (see Staphylococcus) | |||
| Mumps | IgG and IgM serology for recent infection | E8 | IDU |
| Mumps | IgG antibody status | E8 | IDU |
| Mumps | PCR | E8 | IDU |
| Mycobacterium spp. | Identification, genotyping, drug susceptibility, molecular diagnosis (eg PCR for rapid species identification and detection of resistance genes), molecular epidemiological studies, QuantiFERON®-TB Gold test | N1, N4 | NMRS-South |
| Mycoplasma | M.hominis and Ureaplasma spp.: PCR and/or culture | R1 | RVPBRU |
| Mycoplasma | Mycoplasma and ureaplasma: biochemical characterisation and molecular methods | R1 | RVPBRU |
| Mycoplasma | M. pneumoniae: PCR | R1 | RVPBRU |
| Mycoplasma | M. genitalium: molecular detection of the adhesion MgPa gene | B2 | AMRHAI |
| Mycoplasma | Other species: culture, PCR and sequencing when relevant | R1 | RVPBRU |
| Neisseria spp. | N.gonorrhoeae: confirmation of identification by phenotypic and molecular methods | B2 | AMRHAI |
| Neisseria spp. | Susceptibility testing for third-generation cephalosporin and azithromycin antibiotics | B2 | AMRHAI |
| Neisseria spp. | Programme: Gonococcal resistance to antimicrobials surveillance programme (GRASP) | Contact AMRHAI before sending samples | AMRHAI |
| Neisseria meningitidis | Culture identification, molecular epidemiological studies, PCR, serology | Meningococcal reference unit request form | MRU |
| Nipah and Hendra viruses | PCR, isolation | P1 | RIPL |
| Nocardia spp. | Antimicrobial susceptibility | H1, H2 | AMRHAI |
| Noroviruses | RT-PCR | E6 | EVU |
| Noroviruses | Genotyping | E6 | EVU |
| Opportunistic Pathogens | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Orf | Electron microscopy | E17 | HPU |
| Pandoraea spp. | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Parainfluenza virus | Virus detection by PCR (sequencing) | Contact RVU | RVU |
| Parasites, intestinal protozoa and helminths, blood and tissue protozoa and helminths | Contact NPRL | NPRL | |
| Parvovirus B19 | Serology (IgG and IgM) | E9 | IDU |
| Parvovirus B19 | PCR | E9 | IDU |
| Penicillium marneffei | Y1 or Y2 | Mycology RL | |
| Plasmodium spp. | Malaria report form | Malaria RL | |
| Polioviruses | |||
| Polioviruses |
| Polyomavirus JC | PCR | E13 | IDU |
| Pseudomonas spp. | Molecular typing and antimicrobial susceptibility | H1, H2 | AMRHAI |
| PVL (see staphylococcus) | |||
| Q fever (Coxiella burnetii) | P1 | RIPL | |
| Rabies exposure | Contact rabies clerk on 020 8327 6204 | ||
| Rabies diagnosis | Contact rabies clerk on 020 8327 6204 | ||
| Ralstonia spp. | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Respiratory syncytial virus (RSV) | Virus detection by multiplex PCR | Contact RVU | RVU |
| Resistance mechanisms | Molecular detection and confirmation | H1, H2 | AMRHAI |
| Rickettsiae (typhus and spotted fever groups, scrub typhus group) | P1 | RIPL | |
| Rhinovirus | Virus detection by PCR | Contact RVU | RVU |
| Rotavirus | RT-PCR | E1 | EVU |
| Rotavirus | VP6 and NSP4 genotyping | E1 | EVU |
| Rubella | IgG and IgM serology for recent infection | E8 | IDU |
| Rubella | IgG antibody status | E8 | IDU |
| Rubella | PCR | E8 | IDU |
| Salmonella | Identification and typing | L4 | GBRU |
| Sapovirus | RT-PCR | E1 | EVU |
| Severe acute respiratory syndrome (SARS) | See coronavirus. Contact laboratory prior to collection of specimens | E16 | RVU |
| Serratia | Molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Shigella | Identification and typing | L4 | GBRU |
| Staphylococcus | S.aureus: molecular typing | H3, H4 | AMRHAI |
| Staphylococcus | Staphylococcus coagulase negative: species identification and molecular typing | H3, H4 | AMRHAI |
| Staphylococcus | Antimicrobial susceptibility testing | H3, H4 | AMRHAI |
| Staphylococcus | Resistance gene detection | H3, H4 | AMRHAI |
| Staphylococcus | Toxin gene detection (including PVL) | H3, H4 | AMRHAI |
| Stenotrophomonas | S.maltophilia: molecular typing and antimicrobial resistance | H1, H2 | AMRHAI |
| Streptococcus | Streptococcus spp. and related genera or Gram positive cocci: identification | H3, H4 | AMRHAI |
| Streptococcus | S.pyogenes (Lancefield Group A) typing | H3, H4 | AMRHAI |
| Streptococcus | S.agalactiae (Lancefield Group B) typing | H3, H4 | AMRHAI |
| Streptococcus | Lancefield Group C and G typing | H3, H4 | AMRHAI |
| Streptococcus | S. pneumoniae: serological typing | R3 | RVPBRU |
| Streptococcus | Antimicrobial susceptibility | H3, H4 | AMRHAI |
| Tetanus | Tetanus immunity: serum antibodies | R3 | RVPBRU |
| Toxoplasma gondii | Isolation, identification, culture collection, serology (for active infection) molecular diagnostics by PCR | Contact toxoplasma reference laboratory, Swansea | TRL |
| Treponema | T. pallidum (syphilis): serological (please refer to Bristol UKHSA South West) | ||
| Treponema | T.pallidum: PCR | B3 | |
| Unknown haemadsorbing agents | Virus detection by PCR | Contact RVU | RVU |
| Ureaplasma | Refer to mycoplasma | R1 | RVPBRU |
| Varicella-zoster virus (VZV) | IgG serology | E11 | IDU |
| Varicella-zoster virus (VZV) | Intrathecal antibody testing | E22 | IDU |
| Vibrio (including Plesiomonas shigelloides) | Identification and typing | L4 | GBRU |
| Viral haemorrhagic fever (filoviridae, arenaviridae, Bunyaviridae) | Serology, PCR, isolation. Please contact lab before sending samples. | P1 | RIPL |
| VTEC O157 (See Escherichia coli) | |||
| West Nile virus | Serology, PCR | P1 | RIPL |
| Yeasts | Serodiagnosis | Y1 or Y2 | Mycology RL |
| Yellow fever virus | Serology, PCR | P1 | RIPL |
| Yersinia | Identification | L4 | GBRU |
Packaging guidance for infectious disease samples
UKHSA follows the Guidance on regulations for the transport of infectious substances 2013-2014, published by WHO.
Terms and conditions of business
Read the UKHSA terms and conditions of business for all sales and provision of services.
Updates to this page
Published 18 July 2014
Last updated